Merck KGaA header image

Merck KGaA

MRK

Equity

ISIN DE0006599905 / Valor 412799

Xetra (2026-03-05)
EUR 113.20-8.00%

Merck KGaA
UMushroom community rating:

star star star star star
3.00 2 votes No rating yet
NegativeNeutralPositive

About company

Merck KGaA is a global science and technology company headquartered in Darmstadt, Germany, with a history spanning more than 350 years. The company operates across three business sectors: Life Science, Healthcare, and Electronics. In the Life Science sector, Merck provides a wide range of laboratory tools, services, and solutions that support scientific research and bioprocessing for drug manufacturing. The Healthcare division focuses on developing and delivering treatments for serious diseases, including oncology, neurology, immunology, fertility, and endocrinology. Meanwhile, the Electronics sector offers advanced materials, technologies, and solutions for the semiconductor, display, and surface solutions industries. With approximately 63,000 employees in 65 countries, Merck KGaA is dedicated to leveraging science and technology to improve access to health, empower scientific research, and drive human progress through innovation in its diverse fields of operation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-17.4%1Y
-36.6%3Y
-13.0%5Y

Performance

27.7%1Y
26.6%3Y
27.4%5Y

Volatility

Market cap

16975 M

Market cap (USD)

Daily traded volume (Shares)

980,626

Daily traded volume (Shares)

1 day high/low

139.95 / 138.35

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

2 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.25
Tobias Kurz
Switzerland, 30 Mar 2025
star star star star star
-
Theo Clausen
Switzerland, 25 Sep 2024
star star star star star
Currently in a downtrend due to france results, but might surprise us in the future.

EQUITIES OF THE SAME SECTOR

Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.71%USD 16.96
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.62%USD 34.04
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.53%USD 99.64
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.32%USD 42.05
Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc Valor: 115580129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.31%USD 14.10
ImmunityBio Inc
ImmunityBio Inc ImmunityBio Inc Valor: 110468647
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.44%USD 8.96
PTC Therapeutics Inc
PTC Therapeutics Inc PTC Therapeutics Inc Valor: 2515234
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.49%USD 63.33
Krystal Biotech Inc
Krystal Biotech Inc Krystal Biotech Inc Valor: 38026052
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.76%USD 260.33
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.40%USD 20.44
Outset Medical Inc
Outset Medical Inc Outset Medical Inc Valor: 56717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.69%USD 3.44